Kenya, Uganda and South Africa to manufacture own next-generation HIV prevention medicines
- African countries are being backed to develop their own manufacturing capacity for next-generation HIV prevention medicines in a move aimed at reducing reliance on overseas drugmakers.
- Manufacturers in Uganda, Kenya and South Africa are to receive support from global health agency Unitaid to strengthen African production of HIV prevention products.
- Unitaid said strengthening local manufacturing could help create more resilient supply chains while allowing African producers to play a larger role in making medicines for the continent’s own needs.
Unverified
- African countries are being backed to develop their own manufacturing capacity for next-generation HIV prevention medicines in a move aimed at reducing reliance on overseas drugmakers.
- Manufacturers in Uganda, Kenya and South Africa are to receive support from global health agency Unitaid to strengthen African production of HIV prevention products.
- Unitaid said strengthening local manufacturing could help create more resilient supply chains while allowing African producers to play a larger role in making medicines for the continent’s own needs.
Sources: The Independent